Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Regulatory News (OBD)

Share Price Information for Oxford Biodyn (OBD)

Share Price is delayed by 15 minutes
Get Live Data
0.19    0.00 (0.00%)
Bid:
0.18
Ask:
0.20
Spread: 0.02 (11.111%)
Market Cap: £8.15m
OBD Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biodyn Share Chart

Holding(s) in Company

5 Feb 2025 14:11

RNS Number : 0570W
Oxford BioDynamics PLC
05 February 2025
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Oxford Biodynamics plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

X

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Unicorn Asset Management Limited

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

Unicorn AIM VCT plc

City and country of registered office (if applicable)

Teignmouth, Devon, United Kingdom

5. Date on which the threshold was crossed or reachedvi:

03 February 2025

6. Date on which issuer notified (DD/MM/YYYY):

05 February 2025

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

23.00%

23.00%

145,131,526

Position of previous notification (if

applicable)

7.94%

7.94%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary shares GB00BD5H8572

145,131,526

23.00%

SUBTOTAL 8. A

145,131,526

23.00%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting, please identify:

Name of the proxy holder

See Section 4

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Figures are based on total voting rights of 630,919,226

 

Place of completion

Unicorn Asset Management Limited, Preachers Court, Charterhouse, Charterhouse Square, London, EC1M 6AU

Date of completion

05 February 2025

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEALASEENSEFA
Date   Source Headline
6th Feb 202510:46 amRNSHolding(s) in Company
6th Feb 20257:00 amRNSHolding(s) in Company
5th Feb 20252:13 pmRNSHolding(s) in Company
5th Feb 20252:11 pmRNSHolding(s) in Company
5th Feb 20257:00 amRNS-RCRC Test Accurately Detects Cancer and Polyps
4th Feb 20252:38 pmRNSHolding(s) in Company
31st Jan 202512:00 pmRNSResult of GM and Director Dealings
23rd Jan 20257:00 amRNS-RCiRT: Real World Data Presented at ASCO-GI
17th Jan 20257:00 amRNSResult of WRAP Retail Offer
15th Jan 20257:00 amRNSResult of Placing and Subscription
14th Jan 20255:09 pmRNSWRAP Retail Offer
14th Jan 20254:35 pmRNSProposed Fundraising
24th Dec 20247:00 amRNSIssue of shares, Director / PDMR holdings and TVR
19th Dec 20242:41 pmRNSShareholder Loan and Related Party Transaction
16th Dec 20247:00 amRNSDirectorate Change, Funding Update & Joint Broker
6th Dec 20244:05 pmRNSHolding(s) in Company
3rd Dec 20244:41 pmRNSResponse to Share Price Movement
29th Nov 202411:40 amRNSDirector/PDMR Shareholding
28th Oct 202412:12 pmRNSDirector / PDMR holdings and Total Voting Rights
15th Oct 20242:34 pmRNSHolding(s) in Company
14th Oct 20247:00 amRNSCommercial update for FY24
7th Oct 20247:01 amRNSHolding(s) in Company
7th Oct 20247:00 amRNSCIRRP Award Update
11th Sep 202412:55 pmRNSHolding(s) in Company
22nd Aug 20244:59 pmRNSHolding(s) in Company
22nd Aug 202411:41 amRNSHolding(s) in Company
21st Jun 20243:42 pmRNSGrant of Options
18th Jun 20247:00 amRNSHalf-year Report
6th Jun 20247:00 amRNSOBD's PSE test to be used in NCI trial
4th Jun 20247:00 amRNSOBD develops multi-cancer diagnostic test for dogs
24th May 20247:00 amRNSNotice of Results
23rd May 20247:00 amRNSOBD partners with Goodbody Clinic on PSE test
21st May 20247:00 amRNSOBD partners with The London Clinic for PSE & CiRT
16th May 20247:00 amRNSOBD and King's College London collaborate on RA
10th May 20241:11 pmRNSHolding(s) in Company
25th Apr 20242:50 pmRNSHolding(s) in Company
11th Apr 20242:36 pmRNSHolding(s) in Company
10th Apr 20244:28 pmRNSHolding(s) in Company
9th Apr 20245:35 pmRNSHolding(s) in Company
9th Apr 202412:42 pmRNSHolding(s) in Company
9th Apr 202411:56 amRNSHolding(s) in Company
5th Apr 20248:28 amRNSHolding(s) in Company
3rd Apr 202412:57 pmRNSResults of GM
3rd Apr 20247:00 amRNSOBD opens UK clinical testing facility
27th Mar 20242:18 pmRNSResult of AGM
14th Mar 20247:00 amRNSResults of Fundraising
13th Mar 20244:45 pmRNSPrimaryBid Offer
13th Mar 20244:40 pmRNSProposed Fundraising
22nd Feb 20242:30 pmRNSAnnual Report & Accounts
17th Jan 20247:00 amRNSPreliminary Results and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.